CMS Recognizes Tempus for Cutting-Edge Diagnostic Test xT CDx with ADLT Status
Tuesday, 2 July 2024, 10:40
Tempus Receives Prestigious ADLT Status
The Centers for Medicare & Medicaid Services (CMS) has granted Tempus the Advanced Diagnostic Laboratory Test (ADLT) status for its xT CDx test, recognizing its cutting-edge capabilities in precision medicine.
Leadership in Healthcare Innovation
Tempus has solidified its position as a pioneer in healthcare diagnostics with the recent ADLT status award, showcasing dedication to advancing patient care.
- Impactful Recognition: The CMS award underscores the significance of Tempus' xT CDx test in driving diagnostic advancements.
- Leading Precision Medicine: Tempus' focus on precision medicine is further validated through the prestigious ADLT status.
The ADLT status positions Tempus as a key player in shaping the future of diagnostic testing and underscores their commitment to innovation in healthcare.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.